4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0000921895-24-002263
Director sold 2,000,000 shares at $50.00 ($100,003,200)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BVF PARTNERS L P/IL Director | 2024-10-04 | Sale | −1,030,589 | $50.00 | $51,531,099 | 10,235,089 | D |
| BVF PARTNERS L P/IL Director | 2024-10-04 | Sale | −836,862 | $50.00 | $41,844,439 | 8,168,838 | D |
| BVF PARTNERS L P/IL Director | 2024-10-04 | Sale | −132,549 | $50.00 | $6,627,662 | 1,287,768 | D |
| Open-market sales · 2,000,000 sh · avg $50.00 · $100,003,200 | |||||||
Loading xslF345X05/form407422010_10082024.xml…